Endometrial Cancer Research and Education Act of 2024

HR 10439, the Endometrial Cancer Research and Education Act of 2024, directs the National Institutes of Health (NIH) to expand research on endometrial cancer, specifically requiring clinical trials to include at least one African-American woman participant and coordinating with minority health institutes. It also mandates the Centers for Disease Control and Prevention (CDC) to develop and disseminate public education materials about endometrial cancer risk factors, treatments, and disparities - particularly targeting African-American women who face higher mortality rates. The bill authorizes $500,000 annually (2025-2027) for NIH research and necessary funding for the CDC’s education program. It directly affects researchers, healthcare providers, and African-American women, who experience disproportionate rates of aggressive endometrial cancer and mortality. The legislation focuses on addressing documented racial disparities through targeted research and outreach, not on new treatment protocols or healthcare access changes.